data_1fyc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fyc _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.835 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 1' ' ' GLY . 48.8 m -56.03 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 109.475 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -152.88 90.12 1.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.462 ' O ' ' OG ' ' A' ' 5' ' ' SER . 2.5 ptp -130.9 155.43 46.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 4' ' ' MET . 18.9 m -167.19 121.82 1.04 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.577 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER 59.89 151.58 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.48 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 6' ' ' TYR . 35.6 Cg_endo -78.03 155.03 29.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.634 2.223 . . . . 0.0 110.413 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.03 160.64 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.63 2.22 . . . . 0.0 110.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.55 ' CD2' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 177.82 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.376 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.552 ' CG ' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.46 92.67 1.89 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.453 -0.779 . . . . 0.0 109.809 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 13' ' ' LEU . 2.8 mt-30 -45.63 134.51 7.25 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.208 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' CYS . 19.5 m -56.2 -31.33 31.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' N ' ' HA ' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -66.48 149.05 51.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.668 -0.645 . . . . 0.0 110.18 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.525 ' CD1' ' HD2' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -76.44 126.79 85.83 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.469 -0.769 . . . . 0.0 109.467 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 14' ' ' LEU . 36.3 Cg_endo -79.05 80.12 3.18 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.469 2.113 . . . . 0.0 110.481 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' LEU . . . -109.42 -75.62 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER 80.61 5.18 1.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.564 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 20.7 p -175.05 59.0 0.2 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 18' ' ' SER . 36.9 Cg_endo -79.55 0.96 9.61 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.483 2.122 . . . . 0.0 110.205 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m 63.69 12.98 7.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.285 -0.884 . . . . 0.0 108.846 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.47 -164.72 2.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 22' ' ' THR . 92.6 m -150.51 27.17 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.422 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 2.6 ptm -161.48 75.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 48' ' ' THR . . . -111.95 151.4 17.99 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 73' ' ' ARG . 1.2 t -130.1 142.43 50.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -1.094 . . . . 0.0 109.292 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . 3.5 t -45.01 127.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.948 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 3.0 tt0 -91.28 -58.05 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 0.0 110.468 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 8.3 ptm180 -158.59 121.77 3.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.806 -1.184 . . . . 0.0 111.299 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.697 ' O ' ' CG ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -172.46 44.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.257 1.027 . . . . 0.0 109.051 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.87 94.95 0.49 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.797 -1.189 . . . . 0.0 109.808 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HE2' ' CA ' ' A' ' 61' ' ' GLY . 2.6 ttmp? -78.19 167.13 21.86 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' O ' ' C ' ' A' ' 33' ' ' VAL . 9.2 mttt -97.26 113.96 25.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 28.2 m -22.76 137.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' ' HB3' ' A' ' 63' ' ' LEU . . . 43.29 46.82 6.75 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -69.34 -139.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -1.168 . . . . 0.0 109.061 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 158.76 97.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.308 -0.87 . . . . 0.0 109.214 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' CB ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -117.33 149.29 40.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 109.705 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.434 ' C ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -139.05 24.44 2.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' N ' ' HA ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -149.65 20.97 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.13 85.8 1.84 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . 8.5 t0 -82.42 -168.7 2.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -1.122 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 HD22 ' HE3' ' A' ' 31' ' ' LYS . 1.2 pt? -67.46 -169.75 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.256 -0.903 . . . . 0.0 109.318 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HB2' ' N ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -160.92 130.75 4.97 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 109.738 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -47.57 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 108.522 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -81.24 85.69 6.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.519 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 46' ' ' ILE . 1.2 mp -79.44 155.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 109.28 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -160.1 164.31 33.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 3.4 p -143.78 -41.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' THR . 1.3 m-20 161.81 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.05 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 19.67 2.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.385 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 19' ' ' PRO . . . -177.29 163.5 2.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -159.58 119.95 3.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.661 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mm -79.97 171.27 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.089 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.5 ' CA ' HD11 ' A' ' 43' ' ' LEU . . . -154.85 127.08 2.01 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.525 ' N ' ' HB2' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -85.99 55.38 3.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 109.471 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.3 mt-10 -42.57 107.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.536 HG11 ' CB ' ' A' ' 60' ' ' GLU . 2.1 t -90.62 67.02 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.966 . . . . 0.0 109.067 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 47.2 mt-30 -42.46 112.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.897 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 15.3 mt-10 42.19 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 109.557 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 2.0 mt-10 172.57 -164.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 108.912 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 84' ' ' ILE . . . 99.02 60.64 0.87 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.681 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.586 ' O ' ' CG ' ' A' ' 62' ' ' TYR . 36.0 t80 -89.37 4.84 47.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.255 -1.144 . . . . 0.0 108.131 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' HG ' ' HB ' ' A' ' 66' ' ' ILE . 2.1 tt 55.75 72.5 0.48 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.387 -0.82 . . . . 0.0 109.37 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.21 -64.0 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.832 -0.543 . . . . 0.0 109.54 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' CB ' ' CG2' ' A' ' 83' ' ' ILE . 11.6 ttpt -115.28 49.58 1.06 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.59 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -79.79 102.0 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -121.57 -25.26 5.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.272 -178.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.547 ' CG1' ' CB ' ' A' ' 72' ' ' THR . 48.1 t -108.96 98.69 31.36 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 67' ' ' LEU . 34.6 Cg_endo -75.78 160.83 37.22 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.369 2.046 . . . . 0.0 110.521 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -43.72 132.04 5.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.83 -30.64 3.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.547 ' CB ' ' CG1' ' A' ' 68' ' ' VAL . 17.3 m -68.39 133.64 49.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 109.822 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -113.69 106.93 15.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 11.4 m-20 -121.34 -39.66 2.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 168.55 168.65 0.13 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HB2' ' CG ' ' A' ' 19' ' ' PRO . 36.5 Cg_endo -80.37 8.76 3.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.443 2.095 . . . . 0.0 111.116 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' CG ' ' N ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -150.7 -91.49 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.963 -1.086 . . . . 0.0 109.954 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 80' ' ' PRO . . . -39.96 -34.18 0.52 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' LEU . 2.6 t -29.14 88.75 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 CA-C-N 117.696 0.748 . . . . 0.0 111.059 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' N ' ' O ' ' A' ' 78' ' ' GLY . 34.2 Cg_endo -79.68 127.52 7.21 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.721 2.281 . . . . 0.0 109.904 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 1.7 pt? -132.23 -43.47 0.95 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.821 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 56.5 m -155.16 152.1 29.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.311 -1.493 . . . . 0.0 112.554 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG2' ' CB ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -108.02 114.01 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.382 -1.449 . . . . 0.0 109.309 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.552 ' HB ' ' CG ' ' A' ' 10' ' ' MET . 4.0 mp -89.18 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.768 -0.583 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 1.9 p -170.37 -33.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.92 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HA ' ' CB ' ' A' ' 62' ' ' TYR . 14.7 tt0 81.69 28.83 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.741 . . . . 0.0 109.27 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 62' ' ' TYR . 29.5 tttt -43.16 153.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 3.1 tp10 -96.34 -10.71 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 88' ' ' GLU . . . 75.17 138.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 42.9 p-10 -178.09 103.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 92' ' ' SER . 4.2 tt -117.16 154.68 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER 165.33 103.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.408 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -50.42 -72.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 55.86 75.82 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.37 -16.61 51.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.1 161.26 13.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -149.29 82.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -44.54 -53.06 15.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.739 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 35.6 Cg_endo -78.44 -168.47 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.442 2.095 . . . . 0.0 110.339 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.05 -77.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -173.86 2.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.08 11.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -92.66 95.61 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.933 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.76 99.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -63.51 119.04 9.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.477 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.835 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 1' ' ' GLY . 48.8 m -56.03 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 109.475 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -152.88 90.12 1.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.408 ' O ' ' OG ' ' A' ' 5' ' ' SER . 2.5 ptp -130.9 155.43 46.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 6' ' ' TYR . 18.9 m -167.19 121.82 1.04 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER 59.89 151.58 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.48 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 6' ' ' TYR . 35.6 Cg_endo -78.03 155.03 29.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.634 2.223 . . . . 0.0 110.413 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.03 160.64 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.63 2.22 . . . . 0.0 110.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.6 ' ND1' HD11 ' A' ' 83' ' ' ILE . 1.5 t-80 177.82 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.666 ' HB3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.46 92.67 1.89 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.453 -0.779 . . . . 0.0 109.809 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.551 ' HB3' ' CD2' ' A' ' 13' ' ' LEU . 2.8 mt-30 -45.63 134.51 7.25 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.208 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.005 HG12 ' C ' ' A' ' 82' ' ' CYS . 19.5 m -56.2 -31.33 31.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -66.48 149.05 51.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.668 -0.645 . . . . 0.0 110.18 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD13 ' HD2' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -76.44 126.79 85.83 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.469 -0.769 . . . . 0.0 109.467 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.694 ' HD2' HD13 ' A' ' 14' ' ' LEU . 36.3 Cg_endo -79.05 80.12 3.18 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.469 2.113 . . . . 0.0 110.481 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' LEU . . . -109.42 -75.62 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER 80.61 5.18 1.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.577 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 20.7 p -175.05 59.0 0.2 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 18' ' ' SER . 36.9 Cg_endo -79.55 0.96 9.61 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.483 2.122 . . . . 0.0 110.205 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m 63.69 12.98 7.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.285 -0.884 . . . . 0.0 108.846 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.47 -164.72 2.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 22' ' ' THR . 92.6 m -150.51 27.17 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.415 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 2.6 ptm -161.48 75.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.898 ' HA2' HG22 ' A' ' 48' ' ' THR . . . -111.95 151.4 17.99 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.533 ' HB ' ' CB ' ' A' ' 73' ' ' ARG . 1.2 t -130.1 142.43 50.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -1.094 . . . . 0.0 109.292 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . 3.5 t -45.01 127.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.948 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 3.0 tt0 -91.28 -58.05 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 0.0 110.468 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.563 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 8.3 ptm180 -158.59 121.77 3.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.806 -1.184 . . . . 0.0 111.299 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.697 ' O ' ' CG ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -172.46 44.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.257 1.027 . . . . 0.0 109.051 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.87 94.95 0.49 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.797 -1.189 . . . . 0.0 109.808 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HE3' HD21 ' A' ' 42' ' ' LEU . 2.6 ttmp? -78.19 167.13 21.86 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.712 ' C ' HD13 ' A' ' 63' ' ' LEU . 9.2 mttt -97.26 113.96 25.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.91 ' HA ' HD22 ' A' ' 63' ' ' LEU . 28.2 m -22.76 137.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' N ' ' HB3' ' A' ' 63' ' ' LEU . . . 43.29 46.82 6.75 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.841 ' OE1' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -69.34 -139.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -1.168 . . . . 0.0 109.061 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 158.76 97.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.308 -0.87 . . . . 0.0 109.214 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.841 HD23 ' OE1' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -117.33 149.29 40.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 109.705 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -139.05 24.44 2.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' HA ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -149.65 20.97 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' N ' ' H ' ' A' ' 59' ' ' GLU . . . 106.13 85.8 1.84 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . 8.5 t0 -82.42 -168.7 2.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -1.122 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -67.46 -169.75 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.256 -0.903 . . . . 0.0 109.318 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -160.92 130.75 4.97 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 109.738 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.606 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -47.57 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 108.522 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -81.24 85.69 6.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.519 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 46' ' ' ILE . 1.2 mp -79.44 155.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 109.28 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -160.1 164.31 33.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.898 HG22 ' HA2' ' A' ' 24' ' ' GLY . 3.4 p -143.78 -41.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' THR . 1.3 m-20 161.81 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.05 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 19.67 2.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.385 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 19' ' ' PRO . . . -177.29 163.5 2.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -159.58 119.95 3.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.661 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 53' ' ' ILE . 1.1 mm -79.97 171.27 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.089 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.488 ' CA ' HD12 ' A' ' 43' ' ' LEU . . . -154.85 127.08 2.01 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' N ' ' HB2' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -85.99 55.38 3.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 109.471 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.3 mt-10 -42.57 107.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.845 ' CG1' HG21 ' A' ' 84' ' ' ILE . 2.1 t -90.62 67.02 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.966 . . . . 0.0 109.067 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 47.2 mt-30 -42.46 112.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.897 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 15.3 mt-10 42.19 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 109.557 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.607 ' CB ' HG12 ' A' ' 57' ' ' VAL . 2.0 mt-10 172.57 -164.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 108.912 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.774 ' HA2' HG23 ' A' ' 84' ' ' ILE . . . 99.02 60.64 0.87 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.681 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.586 ' O ' ' CG ' ' A' ' 62' ' ' TYR . 36.0 t80 -89.37 4.84 47.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.255 -1.144 . . . . 0.0 108.131 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.91 HD22 ' HA ' ' A' ' 33' ' ' VAL . 2.1 tt 55.75 72.5 0.48 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.387 -0.82 . . . . 0.0 109.37 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . . . -86.21 -64.0 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.832 -0.543 . . . . 0.0 109.54 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.958 ' HB3' HG22 ' A' ' 83' ' ' ILE . 11.6 ttpt -115.28 49.58 1.06 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.829 HD12 ' HB3' ' A' ' 82' ' ' CYS . 0.9 OUTLIER -79.79 102.0 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -121.57 -25.26 5.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.272 -178.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.891 HG13 ' OG1' ' A' ' 72' ' ' THR . 48.1 t -108.96 98.69 31.36 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 67' ' ' LEU . 34.6 Cg_endo -75.78 160.83 37.22 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.369 2.046 . . . . 0.0 110.521 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.563 ' CB ' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -43.72 132.04 5.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.83 -30.64 3.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.891 ' OG1' HG13 ' A' ' 68' ' ' VAL . 17.3 m -68.39 133.64 49.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 109.822 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' CB ' ' HB ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -113.69 106.93 15.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.894 ' O ' HG13 ' A' ' 75' ' ' VAL . 11.4 m-20 -121.34 -39.66 2.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 168.55 168.65 0.13 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HB2' ' CB ' ' A' ' 19' ' ' PRO . 36.5 Cg_endo -80.37 8.76 3.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.443 2.095 . . . . 0.0 111.116 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -150.7 -91.49 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.963 -1.086 . . . . 0.0 109.954 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.646 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -39.96 -34.18 0.52 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.845 ' H ' HG23 ' A' ' 75' ' ' VAL . 2.6 t -29.14 88.75 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 CA-C-N 117.696 0.748 . . . . 0.0 111.059 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.754 ' CB ' HG23 ' A' ' 12' ' ' VAL . 34.2 Cg_endo -79.68 127.52 7.21 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.721 2.281 . . . . 0.0 109.904 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.936 HD23 ' O ' ' A' ' 12' ' ' VAL . 1.7 pt? -132.23 -43.47 0.95 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 1.005 ' C ' HG12 ' A' ' 12' ' ' VAL . 56.5 m -155.16 152.1 29.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.311 -1.493 . . . . 0.0 112.554 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.958 HG22 ' HB3' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -108.02 114.01 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.382 -1.449 . . . . 0.0 109.309 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.845 HG21 ' CG1' ' A' ' 57' ' ' VAL . 4.0 mp -89.18 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.768 -0.583 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' N ' HG22 ' A' ' 84' ' ' ILE . 1.9 p -170.37 -33.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.92 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 14.7 tt0 81.69 28.83 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.741 . . . . 0.0 109.27 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' N ' ' HB3' ' A' ' 62' ' ' TYR . 29.5 tttt -43.16 153.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 3.1 tp10 -96.34 -10.71 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 88' ' ' GLU . . . 75.17 138.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 42.9 p-10 -178.09 103.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 92' ' ' SER . 4.2 tt -117.16 154.68 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER 165.33 103.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.408 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -50.42 -72.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 55.86 75.82 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.37 -16.61 51.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.1 161.26 13.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -149.29 82.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.56 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -44.54 -53.06 15.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.739 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 35.6 Cg_endo -78.44 -168.47 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.442 2.095 . . . . 0.0 110.339 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.05 -77.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -173.86 2.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.08 11.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -92.66 95.61 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.933 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.76 99.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 105' ' ' LEU . 23.6 tp -63.51 119.04 9.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.477 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 1 N--CA 1.529 4.835 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 1' ' ' GLY . 48.8 m -56.03 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 109.475 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -152.88 90.12 1.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.408 ' O ' ' OG ' ' A' ' 5' ' ' SER . 2.5 ptp -130.9 155.43 46.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 6' ' ' TYR . 18.9 m -167.19 121.82 1.04 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER 59.89 151.58 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 109.48 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 6' ' ' TYR . 35.6 Cg_endo -78.03 155.03 29.75 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.634 2.223 . . . . 0.0 110.413 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.03 160.64 30.1 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.63 2.22 . . . . 0.0 110.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.798 ' CD2' HD11 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 177.82 82.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.376 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.666 ' HB3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.46 92.67 1.89 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.453 -0.779 . . . . 0.0 109.809 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.551 ' HB3' ' CD2' ' A' ' 13' ' ' LEU . 2.8 mt-30 -45.63 134.51 7.25 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.208 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.005 HG12 ' C ' ' A' ' 82' ' ' CYS . 19.5 m -56.2 -31.33 31.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -66.48 149.05 51.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.668 -0.645 . . . . 0.0 110.18 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD13 ' HD2' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -76.44 126.79 85.83 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.469 -0.769 . . . . 0.0 109.467 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.694 ' HD2' HD13 ' A' ' 14' ' ' LEU . 36.3 Cg_endo -79.05 80.12 3.18 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.469 2.113 . . . . 0.0 110.481 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' LEU . . . -109.42 -75.62 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER 80.61 5.18 1.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.772 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.577 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 20.7 p -175.05 59.0 0.2 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 18' ' ' SER . 36.9 Cg_endo -79.55 0.96 9.61 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.483 2.122 . . . . 0.0 110.205 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m 63.69 12.98 7.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.285 -0.884 . . . . 0.0 108.846 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.47 -164.72 2.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 22' ' ' THR . 92.6 m -150.51 27.17 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.415 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 2.6 ptm -161.48 75.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.898 ' HA2' HG22 ' A' ' 48' ' ' THR . . . -111.95 151.4 17.99 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.533 ' HB ' ' CB ' ' A' ' 73' ' ' ARG . 1.2 t -130.1 142.43 50.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.34 -1.094 . . . . 0.0 109.292 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . 3.5 t -45.01 127.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.948 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 3.0 tt0 -91.28 -58.05 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.387 -0.821 . . . . 0.0 110.468 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.563 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 8.3 ptm180 -158.59 121.77 3.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.806 -1.184 . . . . 0.0 111.299 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.697 ' O ' ' CG ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -172.46 44.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.257 1.027 . . . . 0.0 109.051 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.87 94.95 0.49 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.797 -1.189 . . . . 0.0 109.808 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HE3' HD21 ' A' ' 42' ' ' LEU . 2.6 ttmp? -78.19 167.13 21.86 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.712 ' C ' HD13 ' A' ' 63' ' ' LEU . 9.2 mttt -97.26 113.96 25.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.91 ' HA ' HD22 ' A' ' 63' ' ' LEU . 28.2 m -22.76 137.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.608 0.718 . . . . 0.0 111.421 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' N ' ' HB3' ' A' ' 63' ' ' LEU . . . 43.29 46.82 6.75 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.841 ' OE1' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -69.34 -139.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -1.168 . . . . 0.0 109.061 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 158.76 97.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.308 -0.87 . . . . 0.0 109.214 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.841 HD23 ' OE1' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -117.33 149.29 40.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.902 -1.124 . . . . 0.0 109.705 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -139.05 24.44 2.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' HA ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -149.65 20.97 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' N ' ' H ' ' A' ' 59' ' ' GLU . . . 106.13 85.8 1.84 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . 8.5 t0 -82.42 -168.7 2.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -1.122 . . . . 0.0 109.562 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -67.46 -169.75 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.256 -0.903 . . . . 0.0 109.318 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -160.92 130.75 4.97 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 109.738 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.606 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -47.57 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 108.522 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -81.24 85.69 6.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.519 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 46' ' ' ILE . 1.2 mp -79.44 155.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.466 -0.771 . . . . 0.0 109.28 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -160.1 164.31 33.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.898 HG22 ' HA2' ' A' ' 24' ' ' GLY . 3.4 p -143.78 -41.57 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' THR . 1.3 m-20 161.81 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.05 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 19.67 2.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.385 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 19' ' ' PRO . . . -177.29 163.5 2.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -159.58 119.95 3.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.661 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 53' ' ' ILE . 1.1 mm -79.97 171.27 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.089 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.488 ' CA ' HD12 ' A' ' 43' ' ' LEU . . . -154.85 127.08 2.01 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' N ' ' HB2' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -85.99 55.38 3.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 109.471 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.3 mt-10 -42.57 107.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.845 ' CG1' HG21 ' A' ' 84' ' ' ILE . 2.1 t -90.62 67.02 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.155 -0.966 . . . . 0.0 109.067 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 47.2 mt-30 -42.46 112.18 0.32 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.839 . . . . 0.0 109.897 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 15.3 mt-10 42.19 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 109.557 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.607 ' CB ' HG12 ' A' ' 57' ' ' VAL . 2.0 mt-10 172.57 -164.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 108.912 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.774 ' HA2' HG23 ' A' ' 84' ' ' ILE . . . 99.02 60.64 0.87 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.681 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.586 ' O ' ' CG ' ' A' ' 62' ' ' TYR . 36.0 t80 -89.37 4.84 47.65 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.255 -1.144 . . . . 0.0 108.131 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.91 HD22 ' HA ' ' A' ' 33' ' ' VAL . 2.1 tt 55.75 72.5 0.48 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.387 -0.82 . . . . 0.0 109.37 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . . . -86.21 -64.0 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.832 -0.543 . . . . 0.0 109.54 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.958 ' HB3' HG22 ' A' ' 83' ' ' ILE . 11.6 ttpt -115.28 49.58 1.06 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.829 HD12 ' HB3' ' A' ' 82' ' ' CYS . 0.9 OUTLIER -79.79 102.0 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -121.57 -25.26 5.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.204 . . . . 0.0 110.272 -178.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.891 HG13 ' OG1' ' A' ' 72' ' ' THR . 48.1 t -108.96 98.69 31.36 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 67' ' ' LEU . 34.6 Cg_endo -75.78 160.83 37.22 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.369 2.046 . . . . 0.0 110.521 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.563 ' CB ' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -43.72 132.04 5.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.83 -30.64 3.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.891 ' OG1' HG13 ' A' ' 68' ' ' VAL . 17.3 m -68.39 133.64 49.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 109.822 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' CB ' ' HB ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -113.69 106.93 15.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.894 ' O ' HG13 ' A' ' 75' ' ' VAL . 11.4 m-20 -121.34 -39.66 2.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 168.55 168.65 0.13 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HB2' ' CB ' ' A' ' 19' ' ' PRO . 36.5 Cg_endo -80.37 8.76 3.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.443 2.095 . . . . 0.0 111.116 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -150.7 -91.49 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.963 -1.086 . . . . 0.0 109.954 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.646 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -39.96 -34.18 0.52 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.845 ' H ' HG23 ' A' ' 75' ' ' VAL . 2.6 t -29.14 88.75 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 CA-C-N 117.696 0.748 . . . . 0.0 111.059 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.754 ' CB ' HG23 ' A' ' 12' ' ' VAL . 34.2 Cg_endo -79.68 127.52 7.21 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.721 2.281 . . . . 0.0 109.904 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.936 HD23 ' O ' ' A' ' 12' ' ' VAL . 1.7 pt? -132.23 -43.47 0.95 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 1.005 ' C ' HG12 ' A' ' 12' ' ' VAL . 56.5 m -155.16 152.1 29.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.311 -1.493 . . . . 0.0 112.554 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.958 HG22 ' HB3' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -108.02 114.01 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.382 -1.449 . . . . 0.0 109.309 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.845 HG21 ' CG1' ' A' ' 57' ' ' VAL . 4.0 mp -89.18 163.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.768 -0.583 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' N ' HG22 ' A' ' 84' ' ' ILE . 1.9 p -170.37 -33.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.92 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 14.7 tt0 81.69 28.83 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.741 . . . . 0.0 109.27 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' N ' ' HB3' ' A' ' 62' ' ' TYR . 29.5 tttt -43.16 153.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 3.1 tp10 -96.34 -10.71 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 88' ' ' GLU . . . 75.17 138.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 42.9 p-10 -178.09 103.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 92' ' ' SER . 4.2 tt -117.16 154.68 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER 165.33 103.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.408 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -50.42 -72.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 55.86 75.82 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.37 -16.61 51.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.1 161.26 13.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -149.29 82.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.56 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -44.54 -53.06 15.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.739 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 98' ' ' ARG . 35.6 Cg_endo -78.44 -168.47 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.442 2.095 . . . . 0.0 110.339 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.05 -77.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -173.86 2.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.08 11.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m -92.66 95.61 9.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.933 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.76 99.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 105' ' ' LEU . 23.6 tp -63.51 119.04 9.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.477 179.994 . . . . . . . . 1 1 . 1 stop_ save_